ELIXF OTC
Elixxer Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +199.1%
1Y: -55.4%
3Y: -97.0%
5Y: -100.0%
$0.03
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.2M
52W Range0.0059-0.0991
Volume4,600
Avg Volume1,073
Beta-0.54
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKarim Mecklai
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2017-12-14
Websiteelixxer.ca
Royal Bank Plaza, South Tower
Toronto, ON M5J 2J1
CA
Toronto, ON M5J 2J1
CA
+1 416 847 1831
About Elixxer Ltd.
Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.
Recent Insider Trades
No insider trades found